Krop og Hormoner ApS: Financial statements 2023
CVR: 38683446
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Krop og Hormoner ApS (CVR 38683446) has filed annual accounts for 2023. In 2023, the company reported a net result of DKK 2,627,957 compared with DKK -15,617 the year before. Equity in the 2023 report amounted to DKK 3,630,174. The solvency ratio was 95%. The company had 1 employee in the financial year.
- Profit/Loss
- DKK 2,627,957
- Equity
- DKK 3,630,174
- Total Assets
- DKK 3,820,527
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | - | 2.6M | 3.6M | 1 |
| 2022 | - | - | -16K | 1M | 1 |
| 2021 | - | -9K | 124K | 1M | 1 |
| 2020 | - | -9K | 801K | 893K | 1 |
| 2019 | - | -6K | 55K | 93K | 1 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Krop og Hormoner ApS has published its annual report for 2022. The net result was DKK -15,617.
About Krop og Hormoner ApS
Krop og Hormoner ApS is a Danish company of the type Anpartsselskab based in Klampenborg, founded in 2017. The company is registered under the industry Traditionelle, komplementære og alternative behandlingsformer. The company was previously named GDL Holding ApS. The management consists of Gitte Elbæk Kobbelgaard Dalberg-Larsen. The company is owned by Gitte Elbæk Kobbelgaard Dalberg-Larsen. The company has 1 employee (2025). In 2025, the company reported a gross profit of DKK 10,394 and a net result of DKK 2,227 compared with DKK 68,042 the year before. Equity in the 2025 report amounted to DKK 3,700,443.